Loading insider details...
Beta
Latest Form 4 (Nov 19, 2025): Grant/Award of 9,761 CNSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 19, 2025 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 9,761 | n/a |
| Nov 14, 2025 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 150,000 | n/a |
| Nov 7, 2024 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 10,000 | n/a |
| Apr 11, 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 83,000 | n/a |
| Feb 6, 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase | 166,666 | $50.0K |
| Aug 16, 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase | 2,750 | $4.9K |
| May 26, 2023 | Moleculin Biotech, Inc. (MBRX) | Grant/Award | 15,000 | n/a |
| May 1, 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Exercise/Conversion | 1,250 | n/a |
| Apr 14, 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Purchase | 15,000 | $10.4K |
| Mar 31, 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 16,467 | n/a |